And a number of candidate compounds to be analyzed.

Roumen studied the three-dimensional structure of the two enzymes using computer simulations and could the dynamic behavior of the enzymes, and a number of candidate compounds to be analyzed. Preferably, this valuable information on the interactions of the enzyme 11B2. By optimizing the interactions between the enzyme and a potential drug it was then a series of a number of highly active and selective compounds. They can be used later as a medicament.

Dutch researcher Luc Roumen has compounds that production of this hormone production of this hormone optimized and saw its optimum dosage. The compounds were applied from Schering-Plough and SymO – Chem BV and a drug patent was made.

They reported Sixteen patients with end-of – treatment positron emission tomography scans were included in the analysis, the mean[ average] % change baseline difference over placebo in cortical amyloid amyloid level was-15.6 % for the 60 – mg group and-35.7 % for the 200-mg group . .

Luc Roumen has developed a new therapy for the prevention of heart failure. The idea is, a drug that blocks the enzyme responsible for the production of aldosterone, namely cytochrome P450 11B2 manage.30th shifts to enhance payment veterinary ‘ Meds.

This information been reprinted from kaiserhealthnews.org with kind permission of Henry J. Kaiser Family Foundation. To can enjoy the full Kaiser Daily Health policy coverage, search the archives and sign up for email delivery of at emperors HealthNews. No information available collected for scientific use, Saunders said.